Literature DB >> 22196314

Experts' recommendations for treating maladaptive aggression in youth.

Elizabeth Pappadopulos1, Nancy Scotto Rosato, Christoph U Correll, Robert L Findling, Judith Lucas, Stephen Crystal, Peter S Jensen.   

Abstract

BACKGROUND: Psychiatric treatment for children and adolescents with clinically significant aggression is common and often involves the use of antipsychotic medications. Increasingly, pediatricians are initiating or managing such treatments despite limited evidence on optimal diagnostic, psychosocial, and medication approaches for pediatric aggression. AIMS: The objective of this study was to gather clinicians' and researchers' expertise concerning the treatment of maladaptive aggression, using expert consensus survey methods to aid the development of guidelines for pediatricians and psychiatrists on the outpatient treatment of maladaptive aggression in youth (T-MAY).
METHODS: Forty-six experts (psychiatrists, pediatricians, and researchers) with >10 years of clinical and/or research experience in the treatment of pediatric aggression completed a 27-item survey (>400 treatment alternatives) about optimal diagnostic, psychosocial, and medication treatments. Data were analyzed using descriptive statistics and confidence intervals.
RESULTS: Expert consensus methodology clearly differentiated optimal versus nonoptimal treatment strategies for maladaptive aggression. In contrast to current practice trends, results indicated that experts support the use of psychosocial interventions and parent education and training before the use of medication for maladaptive aggression at every stage of medication treatment, from diagnosis to maintenance to medication discontinuation.
CONCLUSION: Overall findings indicate that evidence-informed strategies for outpatient treatment of pediatric maladaptive aggression, guided by systematically derived expert opinions, are attainable. In light of the gap between the research literature and clinical practice, expert consensus opinion supports specific practices for optimal outpatient management in children and adolescents with severe and persistent behavioral difficulties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196314      PMCID: PMC3279716          DOI: 10.1089/cap.2010.0128

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  25 in total

1.  National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

Authors:  Mark Olfson; Carlos Blanco; Linxu Liu; Carmen Moreno; Gonzalo Laje
Journal:  Arch Gen Psychiatry       Date:  2006-06

Review 2.  Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.

Authors:  Christoph U Correll
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

3.  Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies.

Authors:  Peter S Jensen; Eric A Youngstrom; Hans Steiner; Robert L Findling; Roger E Meyer; Richard P Malone; Gabrielle A Carlson; Emil F Coccaro; Michael G Aman; James Blair; Donald Dougherty; Craig Ferris; Laurie Flynn; Evelyn Green; Kimberly Hoagwood; Janice Hutchinson; Tom Laughren; Leslie D Leve; Douglas K Novins; Benedetto Vitiello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-03       Impact factor: 8.829

Review 4.  Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials.

Authors:  Peter S Jensen; Jan Buitelaar; Gahan J Pandina; Carin Binder; Magali Haas
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-10-30       Impact factor: 4.785

5.  National trends in psychotherapy by office-based psychiatrists.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  Arch Gen Psychiatry       Date:  2008-08

6.  A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.

Authors:  Robert L Findling; Adelaide Robb; Margaretta Nyilas; Robert A Forbes; Na Jin; Svetlana Ivanova; Ronald Marcus; Robert D McQuade; Taro Iwamoto; William H Carson
Journal:  Am J Psychiatry       Date:  2008-09-02       Impact factor: 18.112

7.  An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.

Authors:  Robert L Findling; Ralph Kauffman; Floyd R Sallee; Daniel E Salazar; Vaishali Sahasrabudhe; Georgia Kollia; David M Kornhauser; Nimish N Vachharajani; Sheila Assuncao-Talbott; Suresh Mallikaarjun; Taro Iwamoto; Robert D McQuade; David W Boulton; Jeffrey Blumer
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

Review 8.  Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

Authors:  Elizabeth Pappadopulos; James C Macintyre Ii; M Lynn Crismon; Robert L Findling; Richard P Malone; Albert Derivan; Nina Schooler; Lin Sikich; Laurence Greenhill; Sarah B Schur; Chip J Felton; Harvey Kranzler; David M Rube; Jeffrey Sverd; Molly Finnerty; Scott Ketner; Sonja E Siennick; Peter S Jensen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-02       Impact factor: 8.829

9.  A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.

Authors:  Magali Reyes; Jan Buitelaar; Paz Toren; Ilse Augustyns; Marielle Eerdekens
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

Review 10.  Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management.

Authors:  Amy H Cheung; Rachel A Zuckerbrot; Peter S Jensen; Kareem Ghalib; Danielle Laraque; Ruth E K Stein
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

View more
  7 in total

1.  Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics.

Authors:  Angie Mae Rodday; Susan K Parsons; Christoph U Correll; Adelaide S Robb; Bonnie T Zima; Tully S Saunders; Laurel K Leslie
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-03       Impact factor: 2.576

Review 2.  Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications.

Authors:  Michael L Birnbaum; Ema Saito; Tobias Gerhard; Almut Winterstein; Mark Olfson; John M Kane; Christoph U Correll
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

3.  Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.

Authors:  Su Xu; Rao P Gullapalli; Douglas O Frost
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

4.  Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function.

Authors:  Monika Vinish; Ahmed Elnabawi; Jean A Milstein; Jesse S Burke; Jonathan K Kallevang; Kevin C Turek; Carien S Lansink; Istvan Merchenthaler; Aileen M Bailey; Bryan Kolb; Joseph F Cheer; Douglas O Frost
Journal:  Int J Neuropsychopharmacol       Date:  2013-01-25       Impact factor: 5.176

5.  Frequency, characteristics and management of adolescent inpatient aggression.

Authors:  Immaculada Baeza; Christoph U Correll; Ema Saito; Dinara Amanbekova; Meena Ramani; Sandeep Kapoor; Raja Chekuri; Marc De Hert; Maren Carbon
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-05-06       Impact factor: 2.576

6.  Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function.

Authors:  Jean A Milstein; Ahmed Elnabawi; Monika Vinish; Thomas Swanson; Jennifer K Enos; Aileen M Bailey; Bryan Kolb; Douglas O Frost
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer Use of Antipsychotics in Youth (SUAY) Clinical Trial.

Authors:  Robert B Penfold; Ella E Thompson; Robert J Hilt; Nadine Schwartz; Adelaide S Robb; Christoph U Correll; Douglas Newton; Kelly Rogalski; Marian F Earls; Robert A Kowatch; Arne Beck; Bobbi Jo H Yarborough; Stephen Crystal; Benedetto Vitiello; Kelly J Kelleher; Gregory E Simon
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-05-04       Impact factor: 8.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.